Home | Volume 24 | Article number 317

Original article

Postoperative keratitis due to Paecilomyces: a rare pediatric case

Postoperative keratitis due to Paecilomyces: a rare pediatric case

Ebru Toker1, Nihan Ziyade2, Serkan Atici3, Kepenekli Kadayifçi Eda3, Özden Türel4, Demet Toprak5, Merih Oray6, Nilgün Cerikcioglu7, Ahmet Soysal3,&, Mustafa Bakir3

 

1Istanbul University, Istanbul Faculty of Medicine, Department of Ophthalmology, Pendik, Istanbul, Turkey, 2The Council of Forensic Medicine, Department of Microbiology, Istanbul, Turkey, 3Marmara University Medical Faculty, Department of Pediatric Infectious Diseases, Pendik, Istanbul, Turkey, 4Bezmialem Vakif University, Department of Pediatric Infectious Diseases, Istanbul, Turkey, 5Boston Childrens Hospital, Department of Pediatric/Urgent Care, USA, 6Istanbul University, Istanbul Faculty of Medicine, Department of Ophthalmology, Pendik, Istanbul, Turkey, 7Marmara University Medical Faculty, Department of Microbiology, Istanbul, Turkey

 

 

&Corresponding author
Ahmet Soysal, Marmara University Medical Faculty, Department of Pediatric Infectious Diseases, Pendik, Istanbul, Turkey

 

 

Abstract

Fungal infections like Paecilomyces keratitis have emerged in childhood recently. The diagnosis and treatment of Paecilomyces keratitis is difficult and the outcome is usually poor. Corneal culture should be performed on fungal media such as Sabouraud glucose neopeptone agar (SDA) as soon as possible for diagnosis. We report a rare case of Paecilomyces keratitis in an immunocompetent child, which was unresponsive to amphotericin B. The case was managed by a multidisciplinary approach involving the departments of ophthalmology, microbiology and pediatric infectious diseases.

 

We want to draw attention once again that fungal keratitis caused by unusual agents are increasing. Physicians should consider fungal causes of keratitis, in patients with some predisposing factors like ocular surgery and prolonged use of topical corticosteroids.

 

 

Introduction    Down

Paecilomyces species are saprobic filamentous fungi and mainly cause ocular infections that frequently followed intraocular lens implantation, trauma and ocular surgery [1]. This fungus can be found in air, soil, wood and decaying vegetation. It is a rare but potentially serious pathogen that causes of filamentous fungal keratitis in children. Paecilomyces species are resistant to many antifungal agents, hence Paecilomyces keratitis treatment is frequently difficult and usually results poor outcome [2]. We report an unusual pediatric case of postoperative Paecilomyces keratitis that required vigorous antifungal treatment-systemic, topical and intracameral, and healed with a vascularized scar. We want to emphasize that corneal sample should performed on fungal media such as Sabouraud glucose neopeptone agar (SDA) as soon as possible in suspected fungal cases. Case management is important for prevent further complications.

 

 

Patient and observation Up    Down

A-14-year-old boy with a history of acute hydrops due to keratoconus in the right eye was treated by keratoplasty. Prednisolone acetate 1% and ciprofloxacin 0.3% eye drops were given postoperatively. On the 30th day after the surgery he complained of severe pain, redness and decreasing vision in the right eye and admitted to hospital. On slit lamp examination, there was a 3x3 mm central abscess on the graft involving all layers of the cornea in the right eye; the left eye examination was normal (Figure 1 A). Corneal scraping was performed and material was obtained for smears and cultures. Corticosteroid eye drop was discontinued and broad-spectrum topical antibiotic therapy with fortified vancomycine (50 mg/ml) and gentamicine (14 mg/ml) was initiated. Treatment was subsequently switched to topical (2%, 6 times a day) and systemic (6 mg/kg intravenous, once a day) fluconazole and topical (0.3%, 6 times a day) amphotericin B since microscopic examination of the corneal scrapings revealed septate branching fungal hyphal structures (Figure 2 A). Amphotericin B was also injected intracamerally at a dosage of 0.005 mg/0.1mL. After 1 week of treatment, the clinical picture deteriorated with elevation of the abscess and impending perforation. The viral and bacterial investigations were negative. In the meantime, mold colonies appeared on SDA (first week of incubation). On examination of fungal culture, the colony was flat, powdery, velvety and yellowish in the obverse side and white to pinkish color in the reverse side. The fungal isolate was identified as a Paecilomyces species by the microbiology laboratory (Figure 2 B). Antifungal therapy was modified to oral terbinafine (250 mg once a day) plus topical (1%, 6 times a day) and systemic (6 mg/kg twice on day 1 and 4 mg/kg twice on the following days, intravenous) voriconazole. Repeat fungal cultures were negative. Clinical improvement was observed and the corneal lesion healed with the vascularized scar tissue (Figure 1 B). Terbinafine and voriconazole were discontinued after, respectively (Figure 1 C, D).

 

 

Discussion Up    Down

Fungal infections are important cause of morbidity and mortality in childhood. More than 70 genera of filamentous fungi and yeasts have been reported to cause fungal keratitis. The reports of fungal ocular infections related with the impared host defense mechanisms have been increased in recent years [3]. Ocular surgery and prolonged use of topical corticosteroids were stated to be the major risk factors associated with fungal keratitis. Paecilomyces species are saprobic, filamentous fungi which belong to hyphomycetes class. All hyaline hyphomycetes, including species of Aspergillus, Scedosporium, Fusarium, Acremonium and Paecilomyces, exhibit similar appearances in clinical specimens on microscopic examination of the infected tissue. Their septate, nonpigmented acute branching (about 45° angles) hyphae render them indistinguishable from each other on microscopic examination. Correlation with culture results and macroscopic morphology is needed for definitive identification at least at the genus level. Once isolated, molds are primarily identified according to their macroscopic morphology on culture media and type of reproductive structures observed microscopically [4]. Paecilomyces species usually cause keratitis, endocarditis, sinusitis, fungemia, pulmonary, cutaneous and subcutaneous infections in an immunocompromised host and similar infections in an immunocompetent host are very rare.

Paecilomyces infections have been reported in patients with or without predisposing factors. About 100 cases of these infections have been reported related to the surgical procedure or immunocompromised hosts [5]. Although Paecilomyces keratitis caused by lilacinus strain is more common, other Paecilomyces strains such as farinosus, marquandii, variotti and viridis keratitis were reported in the literature [6]. A review study showed that 31% of 42 Paecilomyces keratitis cases were associated with chronic keratopathy or previous ocular surgery, 26% appeared following a corneal trauma and 24% occurred in soft contact lens wearers. Other causes were endogenous endophthalmitis and infectious scleritis [7]. Fungal cultures should be obtained as early as possible for diagnosis. Correct identification for fungal pathogen is important for appropriate treatment and to prevent further complications. Antifungal susceptibility tests are not performed routinely for saprobic molds because of difficulties in standardization and reading of the end points.

This case was managed by a multidisciplinary approach involving the departments of ophthalmology, microbiology and pediatric infectious diseases. Experience in the treatment of keratitis due to Paecilomyces species is limited and the optimal antifungal treatment remains unknown. There has been a trend toward using voriconazole, which has the broadest spectrum of the azole antifungals, for the treatment of fungal keratitis. Although P. Lilacinus keratitis is resistant to many antifungal agents, voriconazole has been found effective for treatment. Voriconazole has an excellent topical and oral bioavailability and therapeutic aqueous and vitreous levels are achieved after the topical and oral administration of voriconazole [8, 9]. Terbinafine belongs to the allylamine group of antifungals and inhibits squalene epoxidase, an enzyme involved in sterol metabolism of the cell membrane. Terbinafine and voriconazole combination was synergistic against all tested strains of Paecilomyces [10]. We combined terbinafine with voriconazole to treat and prevent further complications. Anderson et al. also reported a case of Paecilomyces keratitis associated with a retained intracorneal hair that was resistant to routine antifungal agents but was successfully treated with terbinafine and voriconazole combination therapy [3]. Although a treatment algorithm for Paecilomyces keratitis has not been defined, it may be described with additional experiences in the future.

 

 

Conclusion Up    Down

We want to draw attention once again that fungal keratitis caused by unusual agents are increasing. Physicians should consider fungal causes of keratitis, in patients with some predisposing factors like ocular surgery and prolonged use of topical corticosteroids. We also suggest that corneal cultures should be performed. Voriconazole was effective in treatment for keratitis caused by Paecilomyces species.

 

 

Competing interests Up    Down

The authors declare no competing interest.

 

 

Authors’ contributions Up    Down

All authors interested in management, treatment and outcome the patient. All authors have been involved in drafting the manuscript or revising critically for important intellectual content. All authors read and approved the final manuscript.

 

 

Acknowledgements Up    Down

This study is financially supported by the Turkish Academy of Sciences.

 

 

Figures Up    Down

Figure 1: on slit lamp examination (right eye): A) the central corneal abscess with corneal edema and hypopyon on admission; B) healing with vascularized scar on cornea after voriconazole and terbinafine treatment at day 4; C) day 8; D) day 15

Figure 2: A) microscopic examination of corneal scrapings revealed a septate and branching fungal hyphae; B) branching conidiophores arising from infrequent septate hyphae with tapering phialides and chains of conidia characterise Paecilomyces spp (Lactophenol cotton blue stain)

 

 

References Up    Down

  1. Monden Y, Sugita M, Yamakawa R, Nishimura K. Clinical experience treating Paecilomyces lilacinus keratitis in four patients. Clin Ophthalmol. 2012; 6: 949-53. PubMed | Google Scholar

  2. McLintock CA, Lee GA, Atkinson G. Management of recurrent Paecilomyces lilacinus keratitis. Clin Exp Optom. 2013; 96(3): 343-5. PubMed | Google Scholar

  3. Anderson KL, Mitra S, Salouti R, Pham TA, Taylor HR. Fungal keratitis caused by Paecilomyces lilacinus associated with a retained intracorneal hair. Cornea. 2004; 23(5): 516-21. PubMed | Google Scholar

  4. Costa SF, Alexander BD. Diagnosis and treatment of Scedosporium infection. http:// www.uptodate.com/ contents/diagnosis-and-treatment-of-scedosporium-infection. Accessed 7 September 2014. Google Scholar

  5. Hilmarsdottir I, Thorsteinsson SB, Asmundsson P, Bödvarsson M, Arnadottir M. Cutaneous infection by Paecilomyces lilacinus in a renal transplant: treatment with voriconazole. Scand J Infect Dis. 2000; 32(3): 331-2. PubMed | Google Scholar

  6. McLintock CA, Lee GA, Atkinson G. Management of recurrent Paecilomyces lilacinus keratitis. Clin Exp Optom. 2013; 96(3): 343-5. PubMed | Google Scholar

  7. Yuan X, Wilhelmus KR, Matoba AY, Alexandrakis G, Miller D, Huang AJW. Pathogenesis and outcome of Paecilomyces keratitis. Am J Ophthalmol. 2009; 147(4): 691-6. PubMed | Google Scholar

  8. Vemulakonda GA, Hariprasad SM, Mieler WF, Prince RA, Shah GK, Van Gelder RN. Aqueous and vitreous concentrations following topical administration of 1% voriconazole in humans. Arch Ophthalmol. 2008; 126(1): 18-22. PubMed | Google Scholar

  9. Hariprasad SM, Mieler WF, Holz ER, Gao H, Kim JE, Chi J, Prince RA. Determination of vitreous, aqueous and plasma concentration of orally administered voriconazole in humans. Arch Ophthalmol. 2004; 122(1): 42-7. PubMed | Google Scholar

  10. Ortoneda M, Capilla J, Pastor FJ, Pujol I, Yustes C, Serena C, Guarro J. In vitro interactions of approved and novel drugs against Paecilomyces spp. Antimicrob Agents Chemother. 2004; 48(7): 2727-9. PubMed | Google Scholar